Saturday, July 05, 2014 12:39:20 PM
Don't waste my time.
Amarantus' Presentations - AAIC Meeting, July 12-17, 2014 in Copenhagen, Denmark
Employing Lymphocyte Proliferation as a means to Asses Cell Cycle Dys-regulation in Cognitively Impaired Subjects: Clinical Performance of the LymPro Assay
P2-389
11:45am - 2:15pm
Mon, Jul 14
Employing Lymphocyte Proliferation as a means to Asses Cell Cycle Dys-regulation in Cognitively Impaired Subjects: Analytical Performance of the LymPro Assay
P3-117
11:45am - 2:15pm
Tue, Jul 15
Retrospective Analysis of Clinical Prognosis of Subjects from a 2005 study using the LymPro assay
P3-118
11:45am - 2:15pm
Tue, Jul 15
Great time to announce a "big pharma" marketing partnership for LymPro. Roche in the E.U. and Quest Diagnostics in the U.S. would make great partners.
Stay tuned for news.
Note: Jason Napadano tweeted that his next article on Amarantus would be after the AAIC meeting.
Twitter: @AmarantusBio .... 9,955 followers.
p.s. Expecting the share price to move substantially higher from here through the up-listing in 4Q2014. Major milestones ahead.
HealthLynked Corp. Releases Annual Shareholder Letter Highlighting Recent Product Development and Strategic Vision for the Future • HLYK • Feb 4, 2025 8:00 AM
Wytec Wins Multi-State Government Contract for AI Gunshot Detection • WYTC • Feb 3, 2025 7:16 AM
UAV Corp. Retains Legal Counsel to Address Legacy Debt from HTTI Era; 500 Million Authorized Shares Confirmed - UAV Corp. Delivers on Strategic Commitments • UMAV • Jan 31, 2025 1:30 PM
VAYK Closes Acquisition of $1 Million Company • VAYK • Jan 30, 2025 9:52 AM
C2 Blockchain Inc. Secures Regulation A Approval, Prepares to Launch Bitcoin Mining Operations • CBLO • Jan 30, 2025 8:00 AM
Swifty Global Announces Signing of Share Purchase Agreement to be Acquired by Signing Day Sport (NYSE AMERICAN: SGN) • DRCR • Jan 29, 2025 11:19 AM